Skip to main content
Premium Trial:

Request an Annual Quote

Cytomyx Buys Tissue Bank Business from Ardais for $3M

NEW YORK, March 30 (GenomeWeb News) - Cytomyx has bought the tissue bank business from Ardais for $3 million in cash, the Cambridge, UK-based company said today.

 

Cytomyx purchased the newly formed subsidiary of Lexington, Mass.-based Ardais, called Biorepository Business. The subsidiary includes a tissue bank of more than 130,000 human tissue samples with clinical information, primarily from cancer patients. The business also offers tissue microarray and other molecular products as well as immunohistochemistry services. Last year, the business unit had $3.7 million in revenues.

 

Following the acquisition, Cytomyx will relocate its current USbiorepository facility and key personnel from Albany, New York, to Ardais' Lexingtonfacility. Cytomyx will also gain access to Ardais' web-searchable biospecimen management system.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.